Developing new drugs that activate the protective arm of the renin–angiotensin system as a potential treatment for respiratory failure in COVID-19 patients

COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has reached pandemic proportions with negative impacts on global health, the world economy and human society. The clinical picture of COVID-19, and the fact that Angiotensin converting enzyme 2 (ACE2) is a receptor of...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Drug Discov Today
Main Authors: Latil, Mathilde, Camelo, Serge, Veillet, Stanislas, Lafont, René, Dilda, Pierre J.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier Ltd. 2021
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7888990/
https://ncbi.nlm.nih.gov/pubmed/33609783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2021.02.010
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki